N-Allyl-ortho-toluidine → (S)-3-Amino-1-o-tolylazepan-2-one trifluoroacetate
반응식
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[NH2:8][C@H:9]1[CH2:15][CH2:14][CH2:13][CH2:12][N:11]([C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=2OC)[C:10]1=[O:24].[CH2:25](NC1C=CC=CC=1C)C=C>>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[NH2:8][C@H:9]1[CH2:15][CH2:14][CH2:13][CH2:12][N:11]([C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=2[CH3:25])[C:10]1=[O:24]참가 물질
3
실험 절차
(S)-3-Amino-1-o-tolylazepan-2-one trifluoroacetate (17 mg, 0.051 mmol) was synthesized as described for the preparation of Intermediate 62 using N-allyl-2-methylaniline in step A. Anal. Calcd. for C13H18N2O m/z 218.2. found: 219.1 (M+H)+.
출처 및 근거
- ORD 기록
- ord-3d086f5d99794ca1a6be83099bb267b6
- 출처 데이터셋
- uspto-grants-2016_05
- 특허 번호
- US09346852B2
반응 노트
불러오는 중…